Ziyi Chen
Stock Analyst at Goldman Sachs
(2.11)
# 3,078
Out of 4,442 analysts
144
Total ratings
39.8%
Success rate
0.7%
Average return
Main Sectors:
Stocks Rated by Ziyi Chen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LEGN Legend Biotech | Maintained: Buy | $45 → $44 | $29.30 | +49.90% | 6 | May 12, 2026 | |
| HKG: 2359 WuXi AppTec Co., Ltd. | Rated: Buy | $51.00 → $169.40 | $143.20 | +18.30% | 5 | Apr 28, 2026 | |
| HKG: 1530 3SBio Inc. | Maintained: Hold | $33.21 → $29.43 | $16.88 | +74.35% | 7 | Apr 2, 2026 | |
| HKG: 1513 Livzon Pharmaceutical Group Inc. | Downgraded: Sell | $26.02 → $22.99 | $23.82 | -3.48% | 3 | Feb 5, 2026 | |
| HKG: 6821 Asymchem Laboratories (Tianjin) Co., Ltd. | Maintained: Buy | $106.30 → $98.40 | $111.40 | -11.67% | 4 | Oct 31, 2025 | |
| HKG: 2696 Shanghai Henlius Biotech, Inc. | Initiated Coverage: Buy | $100.70 | $64.45 | +56.25% | 1 | Oct 30, 2025 | |
| HKG: 6996 Antengene Corporation Limited | Maintained: Hold | $2.99 → $5.74 | $3.49 | +64.47% | 6 | Oct 27, 2025 | |
| HKG: 1167 Jacobio Pharmaceuticals Group Co., Ltd. | Maintained: Hold | $5.30 → $9.50 | $4.51 | +110.64% | 6 | Oct 27, 2025 | |
| HKG: 1672 Ascletis Pharma Inc. | Maintained: Hold | $14.75 → $12.84 | $10.02 | +28.14% | 5 | Oct 27, 2025 | |
| HKG: 2256 Abbisko Cayman Limited | Initiated Coverage: Buy | $27.10 | $9.31 | +191.08% | 1 | Oct 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $29.30 → $33.50 | $32.98 | +1.58% | 6 | Oct 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $55.70 → $63.30 | $54.00 | +17.22% | 6 | Oct 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20.59 → $22.89 | $11.06 | +106.96% | 5 | Oct 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $3.88 → $4.31 | $3.99 | +8.02% | 3 | Sep 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $3.25 → $3.70 | $1.92 | +92.71% | 7 | Sep 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $9.78 → $10.86 | $4.70 | +131.06% | 7 | Aug 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16.41 → $17.92 | $9.99 | +79.38% | 6 | Aug 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $34.83 → $39.93 | $30.08 | +32.75% | 2 | Aug 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $406.74 → $454.04 | $431.20 | +5.30% | 4 | Aug 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $6.19 | $4.45 | +39.10% | 2 | Jul 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10.26 → $9.62 | $6.76 | +42.31% | 3 | Jul 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $74.95 → $96.22 | $79.30 | +21.34% | 6 | Jul 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $48.32 → $64.27 | $25.36 | +153.43% | 6 | Jul 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $10.01 → $14.92 | $14.64 | +1.91% | 3 | Jul 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $1.57 → $1.35 | $0.98 | n/a | 2 | Apr 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $8.93 → $15.29 | $8.38 | n/a | 5 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $13.98 → $13.44 | $11.93 | n/a | 3 | Apr 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $11.10 → $8.90 | $4.85 | n/a | 2 | Mar 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $282 → $310 | $276.13 | n/a | 5 | Mar 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $29.34 → $28.96 | $11.82 | n/a | 2 | Mar 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $25.60 | $15.77 | n/a | 1 | Oct 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $88 → $73 | $18.50 | n/a | 8 | Oct 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $237.48 | $166.70 | n/a | 1 | Sep 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5.17 | $1.64 | n/a | 1 | Aug 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $4.13 | $2.64 | n/a | 1 | Mar 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $29 → $7.58 | $3.98 | n/a | 2 | Sep 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $10.01 | n/a | 1 | Mar 19, 2020 |
Legend Biotech
May 12, 2026
Maintained: Buy
Price Target: $45 → $44
Current: $29.30
Upside: +49.90%
WuXi AppTec Co., Ltd.
Apr 28, 2026
Rated: Buy
Price Target: $51.00 → $169.40
Current: $143.20
Upside: +18.30%
3SBio Inc.
Apr 2, 2026
Maintained: Hold
Price Target: $33.21 → $29.43
Current: $16.88
Upside: +74.35%
Livzon Pharmaceutical Group Inc.
Feb 5, 2026
Downgraded: Sell
Price Target: $26.02 → $22.99
Current: $23.82
Upside: -3.48%
Asymchem Laboratories (Tianjin) Co., Ltd.
Oct 31, 2025
Maintained: Buy
Price Target: $106.30 → $98.40
Current: $111.40
Upside: -11.67%
Shanghai Henlius Biotech, Inc.
Oct 30, 2025
Initiated Coverage: Buy
Price Target: $100.70
Current: $64.45
Upside: +56.25%
Antengene Corporation Limited
Oct 27, 2025
Maintained: Hold
Price Target: $2.99 → $5.74
Current: $3.49
Upside: +64.47%
Jacobio Pharmaceuticals Group Co., Ltd.
Oct 27, 2025
Maintained: Hold
Price Target: $5.30 → $9.50
Current: $4.51
Upside: +110.64%
Ascletis Pharma Inc.
Oct 27, 2025
Maintained: Hold
Price Target: $14.75 → $12.84
Current: $10.02
Upside: +28.14%
Abbisko Cayman Limited
Oct 26, 2025
Initiated Coverage: Buy
Price Target: $27.10
Current: $9.31
Upside: +191.08%
Oct 17, 2025
Maintained: Hold
Price Target: $29.30 → $33.50
Current: $32.98
Upside: +1.58%
Oct 17, 2025
Maintained: Hold
Price Target: $55.70 → $63.30
Current: $54.00
Upside: +17.22%
Oct 9, 2025
Maintained: Buy
Price Target: $20.59 → $22.89
Current: $11.06
Upside: +106.96%
Sep 3, 2025
Maintained: Sell
Price Target: $3.88 → $4.31
Current: $3.99
Upside: +8.02%
Sep 1, 2025
Maintained: Hold
Price Target: $3.25 → $3.70
Current: $1.92
Upside: +92.71%
Aug 25, 2025
Maintained: Hold
Price Target: $9.78 → $10.86
Current: $4.70
Upside: +131.06%
Aug 19, 2025
Reiterated: Buy
Price Target: $16.41 → $17.92
Current: $9.99
Upside: +79.38%
Aug 19, 2025
Maintained: Buy
Price Target: $34.83 → $39.93
Current: $30.08
Upside: +32.75%
Aug 19, 2025
Maintained: Buy
Price Target: $406.74 → $454.04
Current: $431.20
Upside: +5.30%
Jul 9, 2025
Maintained: Buy
Price Target: $6.19
Current: $4.45
Upside: +39.10%
Jul 9, 2025
Maintained: Buy
Price Target: $10.26 → $9.62
Current: $6.76
Upside: +42.31%
Jul 9, 2025
Maintained: Buy
Price Target: $74.95 → $96.22
Current: $79.30
Upside: +21.34%
Jul 9, 2025
Maintained: Hold
Price Target: $48.32 → $64.27
Current: $25.36
Upside: +153.43%
Jul 9, 2025
Maintained: Sell
Price Target: $10.01 → $14.92
Current: $14.64
Upside: +1.91%
Apr 21, 2025
Maintained: Hold
Price Target: $1.57 → $1.35
Current: $0.98
Upside: n/a
Mar 26, 2025
Maintained: Hold
Price Target: $8.93 → $15.29
Current: $8.38
Upside: n/a
Apr 3, 2024
Maintained: Sell
Price Target: $13.98 → $13.44
Current: $11.93
Upside: n/a
Mar 28, 2024
Maintained: Buy
Price Target: $11.10 → $8.90
Current: $4.85
Upside: n/a
Mar 17, 2024
Maintained: Buy
Price Target: $282 → $310
Current: $276.13
Upside: n/a
Mar 12, 2024
Maintained: Buy
Price Target: $29.34 → $28.96
Current: $11.82
Upside: n/a
Oct 31, 2023
Maintained: Hold
Price Target: $25.60
Current: $15.77
Upside: n/a
Oct 26, 2023
Maintained: Buy
Price Target: $88 → $73
Current: $18.50
Upside: n/a
Sep 20, 2023
Maintained: Buy
Price Target: $237.48
Current: $166.70
Upside: n/a
Aug 30, 2023
Maintained: Buy
Price Target: $5.17
Current: $1.64
Upside: n/a
Mar 27, 2023
Maintained: Hold
Price Target: $4.13
Current: $2.64
Upside: n/a
Sep 29, 2022
Maintained: Buy
Price Target: $29 → $7.58
Current: $3.98
Upside: n/a
Mar 19, 2020
Upgraded: Buy
Price Target: n/a
Current: $10.01
Upside: n/a